Anticoagulants

Open Access
Clinical Pharmacogenomics
Solomon M. Adams, Karryn R. Crisamore and Philip E. Empey

CJASN October 2018, 13 (10) 1561-1571; DOI: https://doi.org/10.2215/CJN.02730218

Add to Selected Citations
You have accessRestricted Access
Risks and Benefits of Direct Oral Anticoagulants across the Spectrum of GFR among Incident and Prevalent Patients with Atrial Fibrillation
Jung-Im Shin, Alex Secora, G. Caleb Alexander, Lesley A. Inker, Josef Coresh, Alex R. Chang and Morgan E. Grams

CJASN August 2018, 13 (8) 1144-1152; DOI: https://doi.org/10.2215/CJN.13811217

Add to Selected Citations
Open Access
Clinical Pharmacology of Oral Anticoagulants in Patients with Kidney Disease
Nishank Jain and Robert F. Reilly

CJASN July 2018, CJN.02170218; DOI: https://doi.org/10.2215/CJN.02170218

Add to Selected Citations
You have accessRestricted Access
Use of Oral Anticoagulation in the Management of Atrial Fibrillation in Patients with ESRD: Verdict 2
Charles A. Herzog

CJASN November 2016, 11 (11) 2095-2096; DOI: https://doi.org/10.2215/CJN.09470916

Add to Selected Citations
You have accessRestricted Access
Use of Oral Anticoagulation in the Management of Atrial Fibrillation in Patients with ESRD: Pro
Peter A. McCullough, Timothy Ball, Katy Mathews Cox and Manish D. Assar

CJASN November 2016, 11 (11) 2079-2084; DOI: https://doi.org/10.2215/CJN.02680316

Add to Selected Citations
You have accessRestricted Access
Use of Oral Anticoagulation for Patients with ESRD on Hemodialysis with Atrial Fibrillation: Verdict 1
Nisha Bansal

CJASN November 2016, 11 (11) 2093-2094; DOI: https://doi.org/10.2215/CJN.08610816

Add to Selected Citations
You have accessRestricted Access
Use of Oral Anticoagulation in the Management of Atrial Fibrillation in Patients with ESRD: Introduction
Paul M. Palevsky

CJASN November 2016, 11 (11) 2078; DOI: https://doi.org/10.2215/CJN.09700916

Add to Selected Citations

Main menu

User menu

Search

Anticoagulants

About

Author Information

More information